• Tutorial
  • Product Matrix
  • Validate
  • Regulatory
  • ROI
  • News
  • Blog
  • Events
  • References
  • LinkedIn Group
  • Training & Consulting
  • Contact

Rapid Micro Methods News

Our news pages will keep you informed of press releases and news articles on RMM technologies, updates from technology suppliers, reviews of recent publications and presentations, and what's changing in the world of rapid methods. You can also follow our news posts on Twitter, Facebook, LinkedIn and RSS.

Follow us on Twitter Follow us on Facebook LinkedIn RSS Feed

Please click here to submit your news

Sunday, June 10, 2018

Lonza and Innosieve Diagnostics Announce Distribution Agreement for Rapid Solid Phase Cytometry Bioburden Test

Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of endotoxin products, services and software and provides pharmaceutical testing professionals with a comprehensive set of quality control (QC) tools.

Under the agreement, Lonza will sell and distribute Innosieve Diagnostics’ solid phase cytometry MuScan™ Instrument, Sieve-ID® Total Viable Count Kit and associated software to the pharmaceutical, biotechnology and medical device manufacturing industries.

Control of bioburden during the manufacturing process is a regulatory requirement for the manufacture of drugs and medical devices. Bioburden testing is performed to assure that the bioburden remains low; however, a major challenge with conventional, growth-based bioburden testing is the lengthy time to results.

Innosieve’s MuScan™ Instrument and Sieve-ID® Total Viable Count Kit offer a non-growth-based bioburden testing approach that enables a single sample to be analyzed within one hour from collection; and up to six samples can be analyzed within two hours. The technology employs solid-state cytometry to detect stained microorganisms that are captured on the patented Sieve-ID® filter. Innosieve’s new 21 CFR Part 11-compliant software then determines the number of viable cells present and records the results in an easy-to-read and auditable report.

Dr. Claus-Dietmar Pein, Head of Business Development for Bioscience Solutions at Lonza Pharma & Biotech, said, “By expanding our QC testing portfolio with this rapid, easy-to-use bioburden testing method, we can help increase product safety, speed up processing time, and reduce costs of bioburden detection as end-users will no longer have to wait several days for their results.”

Dr. Michel Klerks, President and CEO of Innosieve Diagnostics, said, “Having received excellent feedback from our current customers, we are now working with Lonza to supply our innovative bioburden-testing technology to the pharmaceutical and biotechnology QC industries.”

Innosieve will continue to offer its full range of products, including the MuScan™ System, to all other markets.
Posted by RapidMicro at 7:54 AM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)
  • Click to Show All News Articles

Search for News





News Archive

  • ►  2019 (10)
    • ►  February (6)
    • ►  January (4)
  • ▼  2018 (187)
    • ►  December (9)
    • ►  November (16)
    • ►  October (15)
    • ►  September (14)
    • ►  August (18)
    • ►  July (9)
    • ▼  June (24)
      • Portable Magneto-Optical Device can Detect Malaria...
      • Univ. of Florida Team Develops Airborne Flu Detect...
      • False-Negative Rapid Flu Test Results Delay Treatm...
      • UTSA Researchers Create Method that can Quickly an...
      • T2 Biosystems Presents Data on T2Bacteria Panel fo...
      • Luminex Initiates Clinical Trials for VERIGENE II ...
      • Optical Fiber Infrared Spectroscopy Identifies Sep...
      • GenomeDx Biosciences and Pathnostics Launch Enhanc...
      • Detection of Other Viral and Bacterial Diseases Ey...
      • PATH Partners with SD Biosensor to Advance Diagnos...
      • Ugandan Computer Scientist Wins Engineering Prize ...
      • Real-Time Mycoplasma Contamination Detection for B...
      • Bruker Announced Improved Solutions for Microbial ...
      • Curetis Launches Unyvero System and LRT Cartridge ...
      • Lonza and Innosieve Diagnostics Announce Distribut...
      • Micronics PanNAT STEC Test and System Receive FDA ...
      • T2 Biosystems Receives the First FDA Clearance for...
      • CDC Unveils New Rapid Rabies Detection Test
      • Purdue Develops Smartphone System That Rapidly Det...
      • LexaGene’s Prototype for Better Pathogen Detection...
      • FDA Clears Expanded Claims for Cepheid Superbug Te...
      • MicrobeDx Wins CARB-X Funding Award to Advance Its...
      • Genetic Signatures Receives TGA Approval to Market...
      • BacterioScan Receives FDA Clearance For Rapid Infe...
    • ►  May (13)
    • ►  April (15)
    • ►  March (20)
    • ►  February (19)
    • ►  January (15)
  • ►  2017 (115)
    • ►  December (9)
    • ►  November (15)
    • ►  October (10)
    • ►  September (8)
    • ►  August (17)
    • ►  July (12)
    • ►  June (5)
    • ►  May (4)
    • ►  April (11)
    • ►  March (6)
    • ►  February (12)
    • ►  January (6)
  • ►  2016 (127)
    • ►  December (12)
    • ►  November (17)
    • ►  October (11)
    • ►  August (19)
    • ►  July (7)
    • ►  June (16)
    • ►  May (13)
    • ►  April (7)
    • ►  March (8)
    • ►  February (17)
  • ►  2015 (187)
    • ►  December (12)
    • ►  November (12)
    • ►  October (17)
    • ►  September (20)
    • ►  August (10)
    • ►  July (20)
    • ►  June (7)
    • ►  May (11)
    • ►  April (19)
    • ►  March (21)
    • ►  February (23)
    • ►  January (15)
  • ►  2014 (199)
    • ►  December (22)
    • ►  November (16)
    • ►  October (28)
    • ►  September (19)
    • ►  August (11)
    • ►  July (13)
    • ►  June (11)
    • ►  May (17)
    • ►  April (13)
    • ►  March (13)
    • ►  February (19)
    • ►  January (17)
  • ►  2013 (229)
    • ►  December (14)
    • ►  November (20)
    • ►  October (15)
    • ►  September (18)
    • ►  August (8)
    • ►  July (31)
    • ►  June (21)
    • ►  May (18)
    • ►  April (22)
    • ►  March (20)
    • ►  February (15)
    • ►  January (27)
  • ►  2012 (262)
    • ►  December (17)
    • ►  November (26)
    • ►  October (18)
    • ►  September (15)
    • ►  August (22)
    • ►  July (18)
    • ►  June (29)
    • ►  May (23)
    • ►  April (26)
    • ►  March (29)
    • ►  February (20)
    • ►  January (19)
  • ►  2011 (180)
    • ►  December (19)
    • ►  November (15)
    • ►  October (23)
    • ►  September (15)
    • ►  August (20)
    • ►  July (13)
    • ►  June (24)
    • ►  May (16)
    • ►  April (10)
    • ►  March (3)
    • ►  February (14)
    • ►  January (8)
  • ►  2010 (53)
    • ►  December (7)
    • ►  November (8)
    • ►  October (9)
    • ►  September (15)
    • ►  August (3)
    • ►  July (3)
    • ►  June (8)

Popular News Articles

  • Abbott Discontinuing Current Version of Plex-ID PCR System for Smaller Platform Under Development
    Abbott is discontinuing the current version of the Plex-ID system as it prepares for market a next-generation system intended to be smaller...
  • FDA Grants CLIA Waiver Expanding the Availability of Rapid Screening Test for Syphilis
    The U.S. Food and Drug Administration today announced that it granted the first-ever waiver, under certain laboratory regulations, for a rap...
  • DNA Extraction from Samples in a Minute
    Scientists at the Agharkar Research Institute (ARI) in Pune have developed a novel technology to extract bacterial DNA in just a minute from...
  • RPS Announces CE Mark of Rapid Point-Of-Care Test to Help Detect the Body's Immune Response to Viral And Bacterial Infections
    RPS Diagnostics Inc. (RPS®) announced CE mark of its FebriDx™ test clearing the way for sales in the European Union and all countries recogn...
  • Chembio Signs Agreement With CDC Contractor to Develop a Multiplex Point-of-Care Test for Influenza Immunity
    Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered int...
  • A High-Tech Real-Time Solution for Detecting Bacteria in Water
    Water quality and safety can never be taken for granted. Every day, millions of tons of inadequately treated sewage, industrial and agricult...
  • Escherichia coli Serotype O104:H4 Quality Control Strain Now Available from Microbiologics
    Leading biomaterial manufacturer, Microbiologics, has added a new strain of Shiga-toxin producing Escherichia coli (STEC) to their line o...
  • 3M Debuts Food Safety Molecular Detection Assay for Listeria monocytogenes
    The new 3M molecular detection assay for Listeria monocytogenes is the fourth test available for the 3M molecular detection system, which ...
  • MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testing
    MilliporeSigma today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens grow...
  • Devices for Detecting Pathogens in Food on the Production Line
    CIC microGUNE is developing the PREDETEC project, which aims to produce sensors capable of locating infectious agents in food, thanks to the...

Links

  • Microbiology Consultants, LLC
© Copyright 2010-2019 rapidmicromethods.com. All rights reserved. • Terms of Use • Advertise
LinkedIn  LinkedIn   Follow RapidMicro on Twitter  Twitter   Follow RapidMicro on Facebook  Facebook